yperlipidemia is a well-established risk factor for the development of cardiovascular disease and its mortality. 1 Recently, the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, were developed in the clinical setting, and have been demonstrated to have pleiotropic effects in addition to their strong lipid-lowering properties. 2 Several large-scale primary and secondary prevention trials have confirmed that cholesterollowering therapy can reduce the rates of the first occurrence and recurrence of coronary heart disease between 20% and 40%. [3] [4] [5] [6] Moreover, it has been reported that long-term statin therapy improves aortic stiffness, 7 blood pressure, 8 and left ventricular (LV) function. 9-12 Widespread use of noninvasive investigations has enabled detailed evaluation of arterial stiffness 13 and LV systolic and diastolic function, 14,15 so in the present study, we used carotid ultrasonography and newly developed ultrasonic strain imaging to determine whether treatment with pitavastatin contributes to an improvement of carotid arterial stiffness and latent regional LV myocardial function beyond the lipid-lowering effect in patients with hypercholesterolemia and preserved LV ejection fraction (LVEF).
transient ischemic attack, or infectious disease, and/or patients who did not agree to participate in the present study. Two patients in the statin group were receiving antihypertensive therapy before this study, but none of the other patients were taking any medications that could affect hemodynamic or LV ventricular function.
The no statin group received diet and exercise therapy without pitavastatin treatment during the follow-up period. All patients were enrolled in a lifestyle intervention for 1 year. Exercise training included an individualized home exercise program, including a minimum 150 min/week of moderate-intensity physical activity. Dietary modification included personal advice, making the total ingestion of calories into standard body weight ×25 kCal in effect, and abstaining from foods with high cholesterol content.
The normal group consisted of 20 subjects (12 men, 8 women; mean age: 54±8 years) who showed no significant organic cardiovascular disease after routine echocardiography and/or cardiac catheterization for chest pain, dyspnea, or heart murmur on auscultation, and no systemic diseases such as hypertension, diabetes, or hyperlipidemia.
A full clinical history and examination were performed by a specialized physician. Baseline clinical data, cardiovascular risk factors, and cardiovascular medications were recorded. A 12-lead electrocardiogram and routine echocardiogram were reviewed.
All patients gave written informed consent, and the study was approved by the institutional ethics committee because this study was a preventive approach in patients with no previous cardiovascular events, and the event rate is extremely low during the follow-up of 1 year.
Carotid Ultrasonography
We performed carotid ultrasonography at baseline and after 12 months of pitavastatin or no statin therapy in all 30 patients. Ultrasound images were acquired using a 7.5-MHz linear array transducer and Toshiba Power Vision 6000 ultrasound system (Toshiba Medical Systems, Tokyo, Japan). Common carotid artery intima -media thickness (IMT) was determined by high-resolution B-mode ultrasound using a technique validated by Simons et al 13 (Fig 1,  Left) . The right and left common carotid arteries were examined with the head tilted slightly upward in the mid-line position. The transducer was manipulated so that the near and far walls of the common carotid arteries were parallel to the transducer footprint, and the lumen diameter was maximized in the longitudinal plane. The reference point for measurement of the carotid IMT was the region where dilation of the carotid bulb began. On that image, carotid IMT was measured as the leading edges corresponding to the transition zones between lumen -intima and media -adventitia over a length of 1 cm proximal to the reference point. Maximum and mean IMTs were defined as the greatest and mean values, respectively, of IMTs measured from 3 contiguous sites at 1-cm intervals.
Stiffness of the common carotid artery was evaluated by M-mode ultrasonography, and determined by the stiffness index as validated by Hirai et al 16 (Fig 1, Right) ; specifically, stiffness = ln(SBP/DBP)/[(Ds -Dd)/Dd], where Ds and Dd are the end-systolic and end-diastolic diameters of the common carotid artery, respectively, and SBP and DBP are the systolic and diastolic blood pressures, respectively. Maximum and mean IMTs and stiffness s are expressed as the means of both common carotid artery measurements.
Echocardiography
On the M-mode echocardiogram, the LVDd, LVDs, maximal left atrial diameter, end-diastolic thickness of the ventricular septum, and end-diastolic thickness of the LV posterior wall were measured. The percent fractional shortening of the LV was determined using the following equation: percent fractional shortening of the LV (%) = [(LVDdLVDs)/LVDd] ×100.
LV end-diastolic and end-systolic volumes (EDV and ESV, respectively) were calculated from the apical 2-and 4-chamber views using a modified Simpson's method. LVEF was calculated as (LVEDV-LVESV)/LVEDV ×100.
The peak early diastolic velocity (E), the deceleration time from the peak of the early diastolic wave to baseline (E-DT), the peak atrial systolic velocity (A), and the E/A ratio were assessed from the transmitral flow waves using the pulsed Doppler method.
The mitral annular motion velocity was recorded in the LV posterior wall site in the apical LV long-axis view using the pulsed Doppler method. The peak systolic motion velocity (Sw), peak early diastolic motion velocity (Ew), peak atrial systolic motion velocity (Aw), and E/Ew were determined. 14 The acoustic power and filter frequencies of the ultrasound system were set to the lowest values possible, and the sample volumes (width of approximately 8 mm) were set at the mitral annulus of the LV posterior wall.
Strain imaging data were collected from a transthoracic approach using the same system equipped with a 2.5-MHz transducer, and were acquired at a frame rate of 68 frames/s and a sector angle of 30 degrees. The parasternal LV shortaxis view at the level of the chordae tendineae was used to evaluate the LV posterior and inferior walls (Fig 2, Left) . Myocardial strain measurements were performed with an ultrasound system with tissue Doppler capabilities (Power Vision 6000, Toshiba Medical Systems, Ohtawara, Japan) equipped with a 2.5-MHz probe. 17 Patients were placed in the left lateral decubitus position, and the radial strain and strain rate curves were recorded in the LV posterior and inferior walls (Fig 2, Middle and Right). For interpretation of the radial strain and strain rate measurements, after setting the hypothetical center of LV contraction on the LV short-axis view, the velocity data were corrected by the actual Doppler angle ( ) of incidence for each sample region (4×4 mm pixels) in the posterior and inferior walls in the radial direction. A sample region was set along the endocardial sites of the posterior and inferior walls with the reference point for angle-correction placed at the center of LV contraction. Semi-automated tissue tracking kept the regions of interest overriding the subendocardium throughout the cardiac cycle. Image analysis was performed offline on a PC workstation using custom analysis software (ApliQ, Toshiba Medical Systems), and the peak systolic strain (STs), the peak systolic strain rate (SRs), peak early diastolic strain rate (SRe), and peak atrial systolic strain rate (SRa) were determined.
Statistical Analysis
Values are expressed as the mean ± SD. Differences in the mean values between the statin and no statin groups during the follow-up period were compared with the unpaired Student's t-test. The significance of the differences between various parameters for the statin and no statin groups at baseline and after treatment with pitavastatin were tested using the paired t-test. A p-value <0.05 was considered statistically significant.
Results

Clinical Characteristics
There were no significant differences in the clinical characteristics at baseline between the groups (Table 1) . Serum total cholesterol and LDL-C concentrations were significantly lower after pitavastatin therapy in the statin group, whereas there were no significant changes in either variable over time in the no statin group.
Echocardiography
There were no significant differences in the M-mode and 2-dimensional echocardiographic, transmitral flow velocity, and mitral annular motion velocity variables at baseline Fig 2. Representative example of the recording of radial strain (Middle) and strain rate (Right) curves. Yellow squares indicate the regions of interest (4×4 mm pixels) in the left ventricular (LV) posterior and inferior walls (PW and IW, respectively) for the parasternal LV short-axis view at the level of the chordae tendineae (Left). C, LV contraction center chosen at end-systole; A, the angle of motion 90±10°relative to the ultrasound beam, where Doppler calculations are not possible; STs, peak systolic strain; SRs, peak systolic strain rate; SRe, peak early diastolic strain rate; SRa, peak atrial systolic strain rate. between the 2 groups ( Table 2 ). The mean peak systolic strains and early diastolic strain rates for the LV posterior and inferior walls at baseline in the statin and no statin groups tended to be lower and were significantly lower (all p<0.05), respectively, than the age-matched normal subjects (peak systolic strain: 50.4±18.3% in the posterior wall, 53.2±18.2% in the inferior wall; peak early diastolic strain rate: -9.0±2.1 s -1 in the posterior wall, -8.3±1.9 s -1 in the inferior wall). The mean peak systolic strains and early diastolic strain rates for the LV posterior and inferior walls were significantly greater after pitavastatin therapy in the statin group, but these variables did not change significantly after diet and exercise therapy in the no statin group (Table 3, Fig 3) .
Carotid IMT and Stiffness
There were no significant differences in the carotid max and mean IMTs at baseline between the statin and no statin groups, and between before and after treatment with pitavastatin in the statin group (Table 4) . Carotid stiffness was significantly lower after pitavastatin therapy in the statin group, whereas there was no significant change in the stiffness between before and after treatment in the no statin group.
Inter-and Intraobserver Variabilities
The interobserver variability in measurements of carotid and ultrasonic strain imaging parameters was calculated as the difference in 2 measurements performed in the same patient by 2 different observers divided by the mean value. The interobserver variability was 3.2-3.4%. Intraobserver variability also was calculated as the difference between 2 measurements performed in the same patient by 1 observer divided by the mean value. The intraobserver variability was 2.9-3.0%. Table 2 . 
Discussion
In the present study, we demonstrated a clinically substantial benefit beyond the lipid-lowering properties of pitavastatin therapy in patients with hypercholesterolemia. Ultrasonic strain imaging was very useful compared with conventional echocardiography in detecting minute improvements in regional LV function caused by pitavastatin. In addition, pitavastatin led to improvement in carotid artery stiffness.
Cardiovascular risk factors, including abdominal obesity, dyslipidemia, glucose intolerance, and hypertension, 18 contribute to vascular endothelial dysfunction, resulting in the development of atherosclerosis and coronary heart disease. 19 With pulsed Doppler echocardiography, LV diastolic function can now be evaluated noninvasively by recording transmitral flow and mitral annular or LV wall motion velocities. 14, 20 Many studies have indicated that LV diastolic dysfunction occurs before LV systolic dysfunction in patients with hypertension, 21 obesity, 22 dyslipidemia, 23 or diabetes, 24 even in the absence of overt cardiovascular disease.
Mizuguchi et al investigated the relationship between structural and functional changes in the carotid arteries and LV myocardial function in patients with cardiovascular risk factors, and found that LV relaxation is significantly associated with carotid stiffness. 25 Notably, ultrasonic strain imaging revealed subclinical changes in intrinsic myocardial deformation that could not be detected by the conventional methods, including transmitral flow and mitral annular motion velocities, used to evaluate LV function. [25] [26] [27] Statins have several pleiotropic effects, including antiinflammatory and immunomodulatory, antithrombotic, and vascular effects, as well as their beneficial lipid-lowering effects. [28] [29] [30] In the clinical setting, it has been reported that statins improve LV function. Sola et al reported that atorvastatin therapy for 12 months increases LVEF, reduces the LV diameter, and improves several inflammatory markers in patients with nonischemic heart failure. 10 Node et al 11 also found that simvastatin therapy for 14 weeks improves LVEF, decreased the concentrations of plasma brain natriuretic peptide and inflammatory markers in patients with idiopathic dilated cardiomyopathy. They suggested that the anti-inflammatory and antioxidative effects of statins may Representative example of the changes in radial strain (Left) and strain rate (Right) curves of the left ventricular posterior wall before (Top) and after (Bottom) treatment with pitavastatin. The peak systolic strain (STs) and peak early diastolic strain rate (SRe) are markedly increased after pitavastatin therapy. SRs, peak systolic strain rate; SRa, peak atrial systolic strain rate.
play an important role in these outcomes. On the other hand, Bountioukos et al reported that atorvastatin therapy for 6 months dose not improve LVEF, but increases peak systolic mitral annular motion velocity during low-dose dobutamine infusion based on tissue Doppler imaging and dobutamine stress echocardiography, and suggested that the improvement in LV systolic function during dobutamine stress can be attributed to the beneficial effect of atorvastatin on flow-dependent coronary dilation and improvement of endothelial function. 12 In the present study, we demonstrated that pitavastatin therapy improves not only regional LV systolic and diastolic function, but also the carotid arterial stiffness parameter , although there is no significant change in IMT, in patients with hypercholesterolemia and preserved LVEF. In general, atherosclerosis should be evaluated according to the following 2 aspects: atherosis, which reflects structural changes in the intima and media of vascular walls, and sclerosis, which reflects changes in vascular stiffness or distensibility. The carotid IMT used in the present study is an index of atherosis, and the stiffness is an index of sclerosis. Decreased distensibility of the arterial wall increases SBP and decreases DBP, leading to increased LV afterload and impairment of myocardial blood flow because of decreased coronary perfusion pressure. These abnormalities are reflected in the decreased LV diastolic function preceding LV systolic dysfunction. 25, 31 In an experimental study, Ohtsuka et al reported that a decrease in the functional reserve of coronary arterial blood flow is induced by decreasing arterial distensibility, resulting in impaired blood flow in the endocardial layer. 32 Previous findings and the results of the present study suggest that statins may directly improve regional or global LV myocardial function, and secondarily improve LV diastolic function by increasing vascular elasticity. Therefore, our results may be important in the consideration of the diagnostic and therapeutic strategies aimed at cardiac protection in patients with hypercholesterolemia.
Conclusions
One-year pitavastatin treatment improved not only carotid arterial stiffness but also regional LV systolic and diastolic function in patients with hypercholesterolemia and preserved LVEF. Ultrasonic strain imaging has the potential to become a sensitive tool for detecting the effects of early intervention on latent regional LV myocardial dysfunction in this patient population.
